Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2001-8-2
pubmed:databankReference
pubmed:abstractText
Inherited growth-hormone insensitivity (GHI) is a heterogeneous disorder that is often caused by mutations in the coding exons or flanking intronic sequences of the growth-hormone receptor gene (GHR). Here we describe a novel point mutation, in four children with GHI, that leads to activation of an intronic pseudoexon resulting in inclusion of an additional 108 nt between exons 6 and 7 in the majority of GHR transcripts. This mutation lies within the pseudoexon (A(-1)-->G(-1) at the 5' pseudoexon splice site) and, under in vitro splicing conditions, results in inclusion of the mutant pseudoexon, whereas the wild-type pseudoexon is skipped. The presence of the pseudoexon results in inclusion of an additional 36-amino acid sequence in a region of the receptor known to be involved in homo-dimerization, which is essential for signal transduction.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11468686-10591208, http://linkedlifedata.com/resource/pubmed/commentcorrection/11468686-10606636, http://linkedlifedata.com/resource/pubmed/commentcorrection/11468686-10623618, http://linkedlifedata.com/resource/pubmed/commentcorrection/11468686-10938119, http://linkedlifedata.com/resource/pubmed/commentcorrection/11468686-1427786, http://linkedlifedata.com/resource/pubmed/commentcorrection/11468686-1934534, http://linkedlifedata.com/resource/pubmed/commentcorrection/11468686-1948064, http://linkedlifedata.com/resource/pubmed/commentcorrection/11468686-2299664, http://linkedlifedata.com/resource/pubmed/commentcorrection/11468686-2779634, http://linkedlifedata.com/resource/pubmed/commentcorrection/11468686-3779836, http://linkedlifedata.com/resource/pubmed/commentcorrection/11468686-7505286, http://linkedlifedata.com/resource/pubmed/commentcorrection/11468686-7521937, http://linkedlifedata.com/resource/pubmed/commentcorrection/11468686-7534040, http://linkedlifedata.com/resource/pubmed/commentcorrection/11468686-7565946, http://linkedlifedata.com/resource/pubmed/commentcorrection/11468686-7636649, http://linkedlifedata.com/resource/pubmed/commentcorrection/11468686-8045264, http://linkedlifedata.com/resource/pubmed/commentcorrection/11468686-8137822, http://linkedlifedata.com/resource/pubmed/commentcorrection/11468686-8163185, http://linkedlifedata.com/resource/pubmed/commentcorrection/11468686-8253084, http://linkedlifedata.com/resource/pubmed/commentcorrection/11468686-9232273, http://linkedlifedata.com/resource/pubmed/commentcorrection/11468686-9360502, http://linkedlifedata.com/resource/pubmed/commentcorrection/11468686-9419356, http://linkedlifedata.com/resource/pubmed/commentcorrection/11468686-9466995, http://linkedlifedata.com/resource/pubmed/commentcorrection/11468686-9921904
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0002-9297
pubmed:author
pubmed:issnType
Print
pubmed:volume
69
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
641-6
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2001
pubmed:articleTitle
Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity.
pubmed:affiliation
Department of Chemical Endocrinology, St. Bartholomew's Hospital, London EC1A 7BE, United Kingdom.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't